In our Regulatory Snapshot, when we say a country treats Medicinal Cannabis as restricted, it means that products like cannabidiol (CBD) oils are only allowed under formal medicine registration rules. This does not exclude other interpretations, where the same CBD oil may be seen as a herbal medicine, supplement, or even a superfood. In many countries, this remains a “grey area” — a space where entrepreneurs must actively engage and help shape the path forward.
What you'll learn
Table of contents
South Africa Introduction
South Africa is a regional leader in cannabis reform. In 2018, the Constitutional Court decriminalized private adult use and cultivation of cannabis, while medical cannabis is available under prescription via the South African Health Products Regulatory Authority (SAHPRA). Industrial hemp is regulated under the Department of Agriculture, and CBD products have a specific exemption allowing low-dose wellness products. Psilocybin and psychedelics remain strictly prohibited.
---
Cannabis & Wellness Regulation Overview
Recreational Cannabis (Adult Use)
Status: Private use decriminalized, but not commercial.
- 2018 Constitutional Court ruling: adults may possess, cultivate, and use cannabis privately.
- Public consumption, sale, and distribution remain illegal.
- Draft legislation is moving toward a regulated market, but as of 2025, no national commercial framework is in force.
Medical Cannabis
Status: Regulated under SAHPRA.
- Available under Section 21 Authorizations or as registered products.
- Prescribers must obtain SAHPRA approval for patient-specific access to cannabis-based medicines.
- Imports are permitted if products comply with GMP standards.
- Domestic cultivation for medical purposes requires a SAHPRA licence.
Hemp Definition & Industrial Use
Status: Legal, regulated.
- Industrial hemp defined as ≤0.2% THC (in line with international norms).
- Licensing for cultivation overseen by the Department of Agriculture, Land Reform and Rural Development (DALRRD).
- Hemp used for textiles, building materials, food, and wellness products.
CBD Products
Status: Partially deregulated in 2019.
- Low-dose CBD products (≤20 mg daily dose, general wellness claims) are exempt from scheduling — meaning they can be sold over the counter.
- Higher-dose CBD products or therapeutic claims require SAHPRA registration as medicines.
- Enforcement focuses on claims and safety rather than outright bans.
Cosmetics & Artisanal Products
Status: Allowed with restrictions.
- Hemp seed oil widely used.
- CBD in cosmetics permitted under the 2019 exemption, provided THC is absent.
- Products must comply with Cosmetics, Toiletries, and Fragrance Association (CTFA) standards and labeling.
Functional Mushrooms & Adaptogens
Status: Generally unregulated.
- Sold as foods or dietary supplements under the Foodstuffs, Cosmetics, and Disinfectants Act.
- No specific barriers for reishi, lion’s mane, cordyceps, etc.
Psilocybin / Psychedelics
Status: Prohibited.
- Psilocybin is a Schedule 7 controlled substance.
- No decriminalization or medical access framework exists as of 2025.
---
Operating Guidance (Hemp Vegan)
Wellness-Driven Coffee & Retail
South Africa offers strong opportunities in wellness retail and hemp-derived products:
- Choose your space: cafés/wellness hubs centered on superfoods, hemp, mushrooms.
- Plug into the ecosystem: leverage CBD exemption for low-dose products, hemp licensing for retail, and mushrooms as safe entry lines.
- Grow with support: SOPs and legal guardrails for navigating grey areas of commercialization.
Clinical Tools & AI
- Provide protocol guidance for prescribers using medical cannabis (SAHPRA approval flows).
- Track CBD exemption scope for compliant product lines.
- Support patient education in EN + local languages.
---
Marketing, Claims & Compliance
Advertising & Claims
- CBD low-dose products: general wellness claims only.
- No therapeutic claims unless registered as medicines.
- Cannabis medicinal: physician/scientific communication only.
- Functional mushrooms: nutritional/structure-function claims acceptable.
Packaging & Labeling
- CBD products: daily dosage ≤20 mg, clear wellness language, ingredient list, expiry date.
- Hemp foods: nutrition facts, allergen disclosure, labeling in EN/local language.
- Medical cannabis: pharma-grade labeling under SAHPRA rules.
---
Taxes, Import & Duties
- VAT: 15%.
- Hemp and CBD imports regulated by DALRRD + SAHPRA (depending on use).
- Medical cannabis import/export requires SAHPRA authorization and international compliance (INCB oversight).
---
Risks & Practical Notes
- Recreational cannabis: private use permitted, but no commercial retail — high risk for unlicensed sales.
- Medical cannabis: accessible via SAHPRA, but bureaucracy can delay patient access.
- CBD: key opportunity — exemption allows OTC sales if products meet dose/claim limits.
- Strategy: lead with CBD wellness products, functional mushrooms, hemp retail, while building readiness for future recreational regulation.
---
FAQ (Hemp Vegan)
How Hemp Vegan supports operations in South Africa
We map what’s allowed (CBD exemption, hemp, wellness retail), what’s conditional (medical cannabis with SAHPRA licences), and what’s prohibited (public recreational sales), providing compliance roadmaps.
Can CBD be sold freely?
Yes — if ≤20 mg/day, with wellness positioning and no therapeutic claims.
Is psilocybin allowed?
No. Psilocybin is a Schedule 7 drug and strictly prohibited.
---
Sources & Review Log
_Last reviewed_: 2025-08-23
- Constitutional Court of South Africa (2018) — private cannabis use ruling
- SAHPRA — medical cannabis licensing and Section 21 program
- DALRRD Hemp Regulations (2021) — industrial hemp ≤0.2% THC
- Government Gazette Notice (2019) — CBD exemption framework
